9,912 Shares in IDEX Corporation $IEX Bought by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp purchased a new position in shares of IDEX Corporation (NYSE:IEXFree Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 9,912 shares of the industrial products company’s stock, valued at approximately $2,250,000.

Several other hedge funds also recently bought and sold shares of the business. Laurel Wealth Advisors LLC bought a new position in IDEX in the 4th quarter worth about $27,000. Optiver Holding B.V. purchased a new position in IDEX in the first quarter valued at about $27,000. SJS Investment Consulting Inc. boosted its holdings in shares of IDEX by 104.1% in the 1st quarter. SJS Investment Consulting Inc. now owns 149 shares of the industrial products company’s stock valued at $28,000 after buying an additional 76 shares in the last quarter. Quantbot Technologies LP purchased a new position in shares of IDEX in the 2nd quarter worth approximately $33,000. Finally, CYBER HORNET ETFs LLC purchased a new position in IDEX in the second quarter worth $35,000. Institutional investors own 97.96% of the company’s stock.

Key IDEX News

Here are the key news stories impacting IDEX this week:

  • Positive Sentiment: Zacks increased its FY2026 EPS estimate to $8.71 from $8.70, Q4 2026 to $2.20 from $2.18, and Q1 2027 to $2.12 from $2.11.
  • Positive Sentiment: Longer-term estimates also improved: FY2027 EPS rose to $9.26 from $9.21, Q4 2027 to $2.42 from $2.38, Q1 2028 to $2.38 from $2.36, and FY2028 to $10.54 from $10.45. The revisions imply continued earnings growth, although the increases were relatively small.
  • Positive Sentiment: The revised FY2026 estimate of $8.71 remains close to the broader analyst consensus of $8.82. IDEX’s latest reported quarter also showed earnings and revenue ahead of expectations, with EPS of $2.32 and revenue of $920.6 million, up 6.4% year over year.
  • Neutral Sentiment: The six Zacks updates largely repeat the same forecast changes rather than representing separate fundamental developments. Investors may view them as supportive, but the limited size of the revisions may constrain their impact.
  • Neutral Sentiment: IDEX shares have increased and are trading near the upper end of their 52-week range, above both their 50-day and 200-day moving averages. With a market capitalization of approximately $17.3 billion and a forward-looking valuation near 27 times earnings, further gains may depend on the company converting the raised forecasts into actual results.
  • Neutral Sentiment: A separate report concerns IDEX Biometrics ASA (OTC: IDXAF), which granted incentive subscription rights to two senior employees. That company is unrelated to IDEX Corporation and should not affect IEX shares. IDEX Biometrics executive incentive rights announcement

Insider Transactions at IDEX

In related news, CAO Lisa M. Anderson sold 385 shares of the business’s stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $238.59, for a total value of $91,857.15. Following the sale, the chief accounting officer directly owned 4,327 shares in the company, valued at approximately $1,032,378.93. The trade was a 8.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.50% of the company’s stock.

IDEX Price Performance

NYSE:IEX opened at $234.91 on Thursday. IDEX Corporation has a one year low of $158.19 and a one year high of $243.80. The stock has a market cap of $17.32 billion, a PE ratio of 33.80, a P/E/G ratio of 2.17 and a beta of 0.98. The stock has a 50 day moving average price of $228.47 and a 200 day moving average price of $213.48. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.15 and a current ratio of 3.05.

IDEX (NYSE:IEXGet Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, topping the consensus estimate of $2.11 by $0.21. IDEX had a return on equity of 15.69% and a net margin of 14.49%.The business had revenue of $920.60 million for the quarter, compared to analyst estimates of $905.38 million. During the same quarter in the previous year, the firm earned $2.07 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. Equities research analysts expect that IDEX Corporation will post 8.82 EPS for the current fiscal year.

IDEX Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, July 24th. Shareholders of record on Monday, July 6th were given a $0.73 dividend. The ex-dividend date was Monday, July 6th. This represents a $2.92 dividend on an annualized basis and a yield of 1.2%. IDEX’s payout ratio is currently 42.01%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on IEX. TD Cowen boosted their price target on IDEX from $260.00 to $275.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Oppenheimer reaffirmed an “outperform” rating and set a $265.00 price target on shares of IDEX in a research report on Thursday, July 30th. Stifel Nicolaus lifted their target price on shares of IDEX from $257.00 to $268.00 and gave the company a “buy” rating in a report on Thursday, July 30th. Seaport Research Partners restated a “buy” rating and issued a $250.00 price target on shares of IDEX in a research note on Tuesday, May 5th. Finally, Robert W. Baird set a $257.00 price target on shares of IDEX in a report on Thursday, April 30th. Eight analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, IDEX has a consensus rating of “Moderate Buy” and an average price target of $260.80.

View Our Latest Research Report on IEX

About IDEX

(Free Report)

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.

Featured Articles

Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEXFree Report).

Institutional Ownership by Quarter for IDEX (NYSE:IEX)

Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.